FFC#4/2017

Phenotyping new genetically-diverse mouse models mirroring the complexity of the Cystic Fibrosis pathology

FFC#4/2017

Phenotyping new genetically-diverse mouse models mirroring the complexity of the Cystic Fibrosis pathology

PRINCIPAL INVESTIGATOR

Nicola Ivan Lorè (Unità di Infezioni e Fibrosi cistica, Divisione di Immunologia, Trapianti e Malattie Infettive, Ospedale San Raffaele, Milano)

RESEARCHERS

6

CATEGORY

AREA 3 Bronchopulmonary infection

DURATION

2 years

GOAL

€ 92.000 €

RESULTS

Breeding of CC06_ΔF508-/+ heterozygotes does not produce homozygotes mice CC06_ ΔF508-/-, indicating potential premature death in utero for this line. However, CC37_ ΔF508-/+ produces 10% of vital homozygotes mice CC37_ ΔF508-/-. These CF mice showed a significantly lower survival rate post-birth with reduced body weight in comparison to the congenic WT mice. Haematological analysis showed significantly higher neutrophil in CF than WT mice, indicating an ongoing systemic inflammation. Histopathology indicated that CF mice exhibit both the expected CF-related gut pathology and, different from previous models, alterations in the lungs. Bronchial epithelium of CF mice was diffusely hyperplastic with multiple-layers of epithelial and increased of goblet cells. Muco-obstructive alterations in the lungs were observed in the trachea and major bronchi of CF mice. Additional pathological phenotypes have been observed in other organs including pancreas, heart, reproductive tract, spleen, thymus and bone marrow. In conclusion, CC lines greatly expanded the range of disease phenotypes relative to classical inbred strains and may lead to the generation of disease specific mouse model that potentially reproduce the CF human disease.


Congress abstracts

– Sipione B, De Fino I, Viviani F et al. “New-genetically diverse mice to mirror complexity of cystic fibrosis respiratory infections“. 12th European CF Young Investigator Meeting, Paris (France), 21-23 February, 2018

OTHER RESULTS

FFC #3/2024

Two molecules are effective in activating Heat Shock Proteins and enhancing the action of CFTR correctors with the F508del mutation in vitro.

FFC#5/2024

Some peptide nucleic acids (PNAs) re-sensitise Pseudomonas aeruginosa to the antibiotic meropenem in vitro and reduce its virulence.

FFC#1/2023

Tezacaftor, one of the components of Kaftrio, induces an accumulation of dihydroceramides both in vitro and in vivo in animal models